Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors

Clinical trial NCT00003462 · COMPLETED

Trial details

NCT number: NCT00003462
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1998-04-01
Primary completion: 2001-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.